Ewing Sarcoma
📧 Sign up to get email alerts when something new happens for Ewing Sarcoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-07-01Clinical Trial Update: Combination Chemotherapy With or Without Ganitumab in Treating Patients With Newly Diagnosed Metastatic Ewing Sarcoma [Phase 3]
Phase 3 trial evaluating combination chemotherapy with or without ganitumab in newly diagnosed metastatic Ewing sarcoma; status ACTIVE_NOT_R…
-
CLINICAL_TRIALS trial_result · 2022-06-28Clinical Trial Update: Study Evaluating the Safety and Efficacy of Eribulin Mesilate in Combination With Irinotecan Hydrochloride in Children With Refractory or Recurrent Solid Tumors [Phase 1, Phase 2]
Phase 1/2 trial evaluating eribulin mesilate with irinotecan in children with refractory or recurrent solid tumors has completed with result…
-
CLINICAL_TRIALS trial_result · 2022-06-07Clinical Trial Update: Trial of Nab-paclitaxel in Patients With Desmoid Tumors and Multiply Relapsed/Refractory Desmoplastic Small Round Cell Tumors and Ewing Sarcoma [Phase 2]
Phase 2 trial evaluating nab-paclitaxel in desmoid tumors, desmoplastic small round cell tumors, and Ewing sarcoma; study status is complete…
-
CLINICAL_TRIALS trial_result · 2022-01-28Clinical Trial Update: Study to Assess Safety and Preliminary Activity of Eribulin Mesylate in Pediatric Participants With Relapsed/Refractory Rhabdomyosarcoma (RMS), Non-rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS) and Ewing Sarcoma (EWS) [Phase 2]
Phase 2 clinical trial update evaluating safety and preliminary activity of eribulin mesylate in pediatric patients with relapsed/refractory…
-
CLINICAL_TRIALS trial_result · 2021-10-29Clinical Trial Update: Study of Zalypsis® (PM00104) in Patients With Unresectable Locally Advanced and/or Metastatic Ewing Family of Tumors (EFT) Progressing After at Least One Prior Line of Chemotherapy [Phase 2]
Phase 2 trial of Zalypsis (PM00104) in unresectable or metastatic Ewing family tumors progressed after prior chemotherapy; study completed w…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-05-04Clinical Trial Update: Combination Chemotherapy in Treating Patients With Non-Metastatic Extracranial Ewing Sarcoma [Phase 3]
Phase 3 clinical trial update evaluating combination chemotherapy for localized extraskeletal Ewing sarcoma and related peripheral primitive…
-
CLINICAL_TRIALS trial_result · 2021-04-30Clinical Trial Update: Stereotactic Body Radiotherapy (SBRT) for Pulmonary Metastases in Ewing Sarcoma, Rhabdomyosarcoma, and Wilms Tumors [Phase 1, Phase 2]
Phase 1/2 trial evaluating stereotactic body radiotherapy (SBRT) for pulmonary metastases in several pediatric and young adult sarcoma-relat…
-
FDA approval · 2021-01-14FDA Approved: VINCRISTINE SULFATE — Supplemental Application (Hospira, Inc.)
The FDA approved a supplemental application filed by Hospira for vincristine sulfate, a generic vincristine product.
-
CLINICAL_TRIALS trial_result · 2020-09-04Clinical Trial Update: Cabozantinib S-malate in Treating Patients With Relapsed Osteosarcoma or Ewing Sarcoma [Phase 2]
Phase 2 clinical trial update evaluating Cabozantinib S-malate in patients with relapsed or unresectable metastatic osteosarcoma or Ewing sa…
-
CLINICAL_TRIALS trial_result · 2020-06-16Clinical Trial Update: Combination Immunotherapy Targeting Sarcomas [Phase 1, Phase 2]
A clinical trial update for a combination immunotherapy targeting sarcomas across Phase 1 and Phase 2 stages, with conditions including sarc…
-
CLINICAL_TRIALS trial_result · 2020-06-11Clinical Trial Update: Safety and Efficacy Evaluation of 4th Generation Safety-engineered CAR T Cells Targeting Sarcomas [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating fourth-generation safety-engineered CAR T cells for sarcomas, including osteoid sarcoma and Ewing sarc…
-
CLINICAL_TRIALS trial_result · 2020-01-29Clinical Trial Update: Vincristine, Doxorubicin, Cyclophosphamide and Dexrazoxane (VACdxr) in High Risk Ewing's Sarcoma Patients [Phase 2]
Phase 2 trial update of VACdxr regimen for high-risk Ewing's sarcoma; study terminated with posted results.
-
CLINICAL_TRIALS trial_result · 2019-12-17Clinical Trial Update: Co-treatment With GnRH Analogs on the Ovarian Reserve in Young Women Treated With Alkylating Agents for Cancer [Phase 2, Phase 3]
A Phase 2/Phase 3 trial evaluating co-treatment with GnRH analogs to protect ovarian reserve in young women receiving alkylating chemotherap…
-
CLINICAL_TRIALS trial_result · 2019-11-29Clinical Trial Update: A Pilot Study of Tumor-Specific Peptide Vaccination and IL-2 With or Without Autologous T Cell Transplantation in Recurrent Pediatric Sarcomas [Phase 2]
Phase 2 pilot trial evaluating a tumor-specific peptide vaccine with IL-2, with or without autologous T cell transplantation, in recurrent p…
-
CLINICAL_TRIALS trial_result · 2019-10-22Clinical Trial Update: Study in Localized and Disseminated Ewing Sarcoma [Phase 3]
Phase 3 clinical trial in Ewing's Sarcoma (localized and disseminated) has completed.
-
CLINICAL_TRIALS trial_result · 2019-06-18Clinical Trial Update: Differentiation of Bone Sarcomas and Osteomyelitis With Ferumoxytol-Enhanced MRI [Phase 2]
Phase 2 clinical trial updating the use of ferumoxytol-enhanced MRI to differentiate bone sarcomas from osteomyelitis.
-
CLINICAL_TRIALS trial_result · 2019-06-03Clinical Trial Update: Eurosarc Trial of Linsitinib in Advanced Ewing Sarcoma [Phase 2]
Phase 2 trial of linsitinib in relapsed or refractory Ewing sarcoma has completed, with results posted in 2019.
-
FDA approval · 2019-05-20FDA Approved: DACTINOMYCIN — Original Application (XGen Pharmaceuticals DJB, Inc.)
FDA approved the original (ANDA) application for Dactinomycin from XGen Pharmaceuticals DJB, Inc., establishing a generic version of this ch…
-
CLINICAL_TRIALS trial_result · 2019-04-16Clinical Trial Update: Pilot Study of Expanded , Activated Haploidentical Natural Killer Cell Infusions for Sarcomas [Phase 1, Phase 2]
Pilot study investigating expanded, activated haploidentical natural killer cell infusions for Ewing sarcoma and rhabdomyosarcoma across Pha…
-
CLINICAL_TRIALS trial_result · 2019-02-15Clinical Trial Update: Anlotinib and Irinotecan for Ewing Sarcoma [Phase 1, Phase 2]
Clinical Trial Update: a Phase 1/2 study evaluating the combination of Anlotinib and Irinotecan for metastatic Ewing sarcoma.
-
CLINICAL_TRIALS trial_result · 2019-01-10Clinical Trial Update: Study of Talazoparib, a PARP Inhibitor, in Patients With Advanced or Recurrent Solid Tumors [Phase 1]
Phase 1 trial of talazoparib in advanced or recurrent solid tumors shows safety data and preliminary activity; results posted.
-
CLINICAL_TRIALS trial_result · 2018-12-27Clinical Trial Update: Study to Find a Safe Dose and Show Early Clinical Activity of Weekly Nab-paclitaxel in Pediatric Patients With Recurrent/ Refractory Solid Tumors [Phase 1, Phase 2]
A pediatric Phase 1/2 study assessed the safety and early activity of weekly nab-paclitaxel in children with recurrent or refractory solid t…
-
CLINICAL_TRIALS trial_result · 2018-09-18Clinical Trial Update: Haploidentical Stem Cell Transplantation and NK Cell Therapy in Patients With High-risk Solid Tumors [Phase 2]
Phase 2 clinical trial evaluating haploidentical stem cell transplantation with NK cell therapy in high-risk solid tumors, including neurobl…
-
CLINICAL_TRIALS trial_result · 2018-08-01Clinical Trial Update: Study of Intensive Chemotherapy, Surgery and Radiotherapy to Treat Ewing's Sarcoma in Children and Young Adults [Phase 2]
Phase 2 trial evaluating intensive chemotherapy, surgery, and radiotherapy for Ewing's Sarcoma in children and young adults has been complet…
-
CLINICAL_TRIALS trial_result · 2018-07-17Clinical Trial Update: A Five-Tier, Open-Label Study of IMC-A12 in Advanced Sarcoma [Phase 2]
Open-label Phase 2 study of IMC-A12 (cixutumumab) in advanced sarcomas. Results were posted in 2018.